Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Multi-kinase capsule for kidney cancer and GIST. | Multi-kinase tablet for liver, kidney and thyroid cancers. |
| Body system | Cancer | Cancer |
| Drug class | Tyrosine kinase inhibitors | Tyrosine kinase inhibitors |
| Supply | Prescription onlyWHO essential medicine | Prescription only |
| Main uses | Advanced kidney cancer, Gastrointestinal stromal tumour (GIST), Pancreatic neuroendocrine tumours | Hepatocellular (liver) cancer, Advanced kidney cancer, Differentiated thyroid cancer |
| How it works | Slows tumour growth and blood supply. | Slows tumour growth and blood supply. |
| Starts working | Depends on the cancer and regimen | Depends on the cancer and regimen |
| Half-life | 40–60 hours (sunitinib); 80–110 hours (metabolite) | 25–48 hours |
| Typical adult dose | Dosed by your cancer team according to the treatment protocol. | Dosed by your cancer team according to the treatment protocol. |
| Forms | Capsule | Tablet |
| Common side effects | Tiredness, Diarrhoea, High blood pressure, Mouth sores, Yellowing of skin, Hand-foot syndrome | Hand-foot skin reaction, Diarrhoea, High blood pressure, Rash, Tiredness |
| Serious side effects | Heart failure, Liver failure, Underactive thyroid, Bleeding | Bleeding, Heart problems, Liver injury, Bowel perforation |
| Don't take if | Pregnancy; Uncontrolled high blood pressure; Severe liver impairment | Pregnancy; Uncontrolled high blood pressure |
| Alcohol | Best to limit. Alcohol may add to liver strain. | Best to limit. Alcohol may add to liver strain. |
| Pregnancy | Usually avoidedAvoid. | Usually avoidedAvoid. |
| Breastfeeding | Usually avoidedAvoid. | Usually avoidedAvoid. |
| In use since | — | — |
| Brand names | United States: SutentUnited Kingdom: SutentIndia: Sutent, Sunitinib (generic), Sutinib | United States: NexavarUnited Kingdom: NexavarIndia: Nexavar, Sorafenib (generic), Soranib |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | L01EX01 | — |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker